Diabetes Injection Pens Market is Expected to be Worth US$9.7 Billion by 2024 - Leading Players Operating are Novo Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A - Seite 2
The demand for diabetes injection pens is also expected to be fueled by the increasing cases of needle stick injuries. Usage of needles can lead to percutaneous piercing wounds due to incorrect handling, disassembling, or disposing. Owing to this, several healthcare professionals are promoting the usage of injection pens for administering insulin. Design and development of diabetes injection pens that are safe, easy to use, cost-effective, and relatively pain-free are also likely to encourage type 1 diabetics to use them.
Availability of Substitutes Restricts Market Growth
The steady market growth will waver due to the growing number of substitutes in the market. The introduction of a wide range of technologies that offer substitute products is likely to hamper market growth. Furthermore, the possibility of artificial pancreas and disposable insulin patches are also projected to have a negative impact on the global market in the coming years. Poor reimbursement policies for diabetes injection pens is also restraining the growth rate of the global market.
Get Exclusive Discounts on Report Purchase: http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=8806
This review is based on Transparency Market Research's report, titled "Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2016 - 2024."
The global diabetes injection pens market is segmented as follows:
Global Diabetes Injection Pens Market, by Product Type
- Insulin Pens
- Pen Needles
Lesen Sie auch
Global Diabetes Injection Pens Market, by Usage
- Reusable Pens
- Disposable Pens
Global Diabetes Injection Pens Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics/ Centers
Global Diabetes Injection Pens Market, by Geography
-
North America
- U.S.
- Canada
-
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of the Europe
-
Asia
- China
- Japan
- India
- Indonesia
- Malaysia
- Rest of Asia
-
Latin America (LATAM)
- Brazil
- Mexico
- Rest of LATAM
- Rest of World
- Australia & New Zealand
- South Africa
- RoW
Browse Related Research Report: